Phosphate Therapeutics
Manchester
About Phosphate Therapeutics
Phosphate Therapeutics, a UK-based independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals. The company intends to use the capital to complete the Phase 2 development of its phosphate binder (PT20) for the treatment of a late-stage renal disease suffer from systemic phosphate accumulation, hyperphosphataemia, whose global rights were acquired from the Medical Research Council.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $13.9M
- Last round: Series Unknown (Mar 2012)
- Website: phosphatetx.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/phosphate-therapeutics-2798323 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.